Waystar Holding Corp stock edges lower as client win highlights revenue potential

Waystar Holding Corp stock (ISIN US94419L1017) traded around USD 25.53 on September 21, 2026 as investors weighed a fresh client success story against a broadly positive analyst stance on the Nasdaq-listed healthcare payments platform.

Client win delivers USD 6.32 million boost

As TradersUnion reported on September 21, 2026, Waystar highlighted that client AnMed secured an additional USD 6.32 million in payments by using its revenue management offerings, achieving a 4:1 return on investment.

According to the same overview from TradersUnion, Waystar stock edged lower on that day, changing hands at USD 25.53 as investors digested the client milestone within the broader valuation picture.

Analysts keep Moderate Buy view and higher targets

Analyst sentiment toward Waystar remains constructive, even as the share price has softened in recent trading.

According to MarketBeat on September 21, 2026, Waystar currently carries a consensus rating of Moderate Buy based on two Strong Buy ratings, eighteen Buy recommendations and four Hold ratings.

The same analyst data compiled by MarketBeat show an average price target of USD 34.67 per share for Waystar.

With the stock opening at USD 25.66 on September 21, 2026 in the same MarketBeat overview, this implies that the consensus target sits roughly USD 9.01 above that level, pointing to around 35.1 percent upside if analysts' expectations are met.

The MarketBeat data also highlight individual rating changes, noting that Barclays lowered Waystar from an overweight rating to an equal weight stance while raising its price target from USD 27.00 to USD 30.00 in a research report dated September 15, 2026, underscoring a more cautious relative view but still a higher price expectation than recent trading levels.

Stock trades below analyst targets

For investors, the quantified gap between Waystar's current share price and the analyst consensus target is a key reference point.

Per MarketBeat, Waystar stock opened at USD 25.66 on September 21, 2026, while the same data set place the average price target at USD 34.67, a differential that supports the view of potential re-rating if operating performance and client wins like the AnMed case continue.

Although detailed quarterly revenue and earnings figures are not highlighted in the week-filtered sources, the combination of a concrete USD 6.32 million revenue recovery for a single client and a median analyst target well above the current price level suggests that expectations for Waystar's revenue-cycle technology remain intact even as the stock faces short-term volatility.

Waystar stock price and market data

Based on the MarketBeat and TradersUnion data snapshots as of September 21, 2026, Waystar stock traded in the mid-USD 20 range on its primary listing, with intraday levels such as USD 25.53 and an opening price of USD 25.66 indicating a modest pullback relative to the analyst consensus value.

More news and analyses on Waystar Holding Corp stock